High-dose-rate brachytherapy for previously irradiated patients with recurrent esophageal cancer
- 26 October 2007
- journal article
- Published by Springer Nature in Radiation Medicine
- Vol. 25 (8) , 373-377
Abstract
Our objective was to assess the feasibility, efficacy, and complications of high-dose-rate (HDR) brachytherapy for patients with recurrent esophageal cancer after external radiotherapy. Six patients with recurrent esophageal cancer after external radiotherapy were treated with HDR brachytherapy (Ir-192 source) from January 2003 to February 2004. The median age of the patients was 69 years. All patients had received external radiotherapy (median dose 60 Gy) before HDR brachytherapy. All patients underwent HDR brachytherapy once a week with a dose of 4 or 5 Gy per fraction in the esophageal mucosa (median total dose 20 Gy). The Kaplan-Meier method was used to calculate local control rates. The median overall survival period was 30.0 months. Local control was observed in five patients and residual tumor in one patient. Persistent local control was observed in two patients. No patient died of esophageal cancer, and all patients survived. We observed no severe late complications related to HDR brachytherapy. These data suggest that HDR brachytherapy is an effective and safe treatment for patients with recurrent esophageal cancer after external radiotherapy.Keywords
This publication has 15 references indexed in Scilit:
- Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancerBritish Journal of Radiology, 2005
- Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- The role of brachytherapy for palliationSeminars in Radiation Oncology, 2000
- Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in JapanInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- High-dose-rate brachytherapy boost following concurrent chemoradiotherapy for esophageal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Chemoradiotherapy of Locally Advanced Esophageal CancerJAMA, 1999
- Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the EsophagusNew England Journal of Medicine, 1997
- Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancerEuropean Journal of Cancer, 1997
- Effective palliation for advanced esophageal cancer using intralumenal irradiation.1996